Aside from clinical staging, previous studies have identified CD38, ZAP‐70, cytogenetic abnormality, serum β2‐microglobulin (β2‐MG), and serum lactate dehydrogenase (LDH) as prognostic factors for CLL.1, 17. This evidence concerns the gene HLA-G and B-cell chronic lymphocytic leukemia.